Balancing the efficacy vs. the toxicity of promiscuous natural products_Paclitaxel-based acid-labile lipophilic prodrugs as promising chemotherapeutics Read More »
Dose-Escalating Safety and Toxicokinetics of a Paclitaxel Prodrug and of Paclitaxel after Pseudo-LDL Delivery to the Beagle Read More »
Pharmacokinetics of a Paclitaxel Prodrug and of Paclitaxel After Pseudo-LDL Delivery to Tumor-Xenografted Mice Read More »
Preclinical Characterization of Pseudo-LDL Tumor Targeting of a Lipophilic Prodrug of Paclitaxel Read More »
